{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:30:21Z","timestamp":1761823821931},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T00:00:00Z","timestamp":1471824000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12876-016-0516-2","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T13:55:37Z","timestamp":1471874137000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of hepatitis B and clinical outcomes in inflammatory bowel disease patients in a viral-endemic region"],"prefix":"10.1186","volume":"16","author":[{"given":"Heyson C. H.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent W. S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace L. H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whitney","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin C. Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siew C.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"issue":"8","key":"516_CR1","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/j.1440-1746.2012.07150.x","volume":"27","author":"L Prideaux","year":"2012","unstructured":"Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol. 2012;27(8):1266\u201380.","journal-title":"J Gastroenterol Hepatol"},{"key":"516_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.gastro.2013.04.007","volume":"145","author":"SC Ng","year":"2013","unstructured":"Ng SC, Tang W, Ching J, et al. Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn\u2019s and Colitis Epidemiology Study. Gastroenterology. 2013;145:158\u201365.","journal-title":"Gastroenterology"},{"issue":"6","key":"516_CR3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/ibd.21284","volume":"16","author":"JK Hou","year":"2010","unstructured":"Hou JK, Velayos F, Terrault N, Mahadevan U. Viral hepatitis and inflammatory bowel disease. Inflamm Bowel Dis. 2010;16(6):925\u201332.","journal-title":"Inflamm Bowel Dis"},{"key":"516_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1365-2036.2010.04570.x","volume":"33","author":"JP Gisbert","year":"2011","unstructured":"Gisbert JP, Chaparro M, Esteve M. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33:619\u201333.","journal-title":"Aliment Pharmacol Ther"},{"key":"516_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.crohns.2012.03.001","volume":"7","author":"A Papa","year":"2013","unstructured":"Papa A, Felice C, Marzo M, et al. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-\u03b1 agents. J Crohns Colitis. 2013;7:113\u20139.","journal-title":"J Crohns Colitis"},{"key":"516_CR6","unstructured":"Surveillance of Viral Hepatitis in Hong Kong - 2012 Update Report. http:\/\/www.info.gov.hk\/hepatitis\/doc\/hepsurv12.pdf . Accessed 5 Feb 2014"},{"key":"516_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/00054725-200111000-00002","volume":"7","author":"L Biancone","year":"2001","unstructured":"Biancone L, Pavia M, Del Vecchio Blanco G, et al. Hepatitis B and C virus infection in Crohn\u2019s disease. Inflamm Bowel Dis. 2001;7:287\u201394.","journal-title":"Inflamm Bowel Dis"},{"key":"516_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ajg.2008.4","volume":"104","author":"C Loras","year":"2009","unstructured":"Loras C, Saro C, Gonzalez-Huix F, et al. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: A nationwide, multicenter study. Am J Gastroenterol. 2009;104:57\u201363.","journal-title":"Am J Gastroenterol"},{"key":"516_CR9","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/ibd.21147","volume":"16","author":"J Chevaux","year":"2010","unstructured":"Chevaux J, Nani A, Oussalah A, et al. Prevalence of Hepatitis B and C and Risk Factors for Non-vaccination in Inflammatory Bowel Disease Patients in Northeast France. Inflamm Bowel Dis. 2010;16:916\u201324.","journal-title":"Inflamm Bowel Dis"},{"key":"516_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.crohns.2010.03.001","volume":"4","author":"KH Katsanos","year":"2010","unstructured":"Katsanos KH, Tsianos VE, Zois CD, et al. Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature. J Crohns Colitis. 2010;4:450\u201365.","journal-title":"J Crohns Colitis"},{"key":"516_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"A Lok","year":"2009","unstructured":"Lok A, McMahon B. Chronic Hepatitis B: Update 2009. Hepatology. 2009;50:661.","journal-title":"Hepatology"},{"key":"516_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2011.11.030","volume":"57","author":"G Papatheodoridis","year":"2012","unstructured":"Papatheodoridis G, Buti M, Cornberg M, et al. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection EASL. J Hepatol. 2012;57:167.","journal-title":"J Hepatol"},{"issue":"3","key":"516_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12072-008-9080-3","volume":"2","author":"YF Liaw","year":"2008","unstructured":"Liaw YF, Leung N, Kao JH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int. 2008;2(3):263\u201383.","journal-title":"Hepatol Int"},{"issue":"6","key":"516_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","volume":"8","author":"J-F Rahier","year":"2014","unstructured":"Rahier J-F, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn\u2019s Colitis. 2014;8(6):443\u201368.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"10","key":"516_CR15","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/gut.2010.208413","volume":"59","author":"C Loras","year":"2010","unstructured":"Loras C, Gisbert JP, Minguez M, et al. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut. 2010;59(10):1340\u20136.","journal-title":"Gut"},{"issue":"1","key":"516_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/j.gastro.2014.10.039","volume":"148","author":"KR Reddy","year":"2015","unstructured":"Reddy KR, et al. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology. 2015;148(1):215\u20139.","journal-title":"Gastroenterology"},{"key":"516_CR17","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/ibd.22905","volume":"18","author":"SH Park","year":"2012","unstructured":"Park SH, Yang SK, Lim YS, et al. Clinical Courses of Chronic Hepatitis B Virus Infection and Inflammatory Bowel Disease in Patients with Both Diseases. Inflamm Bowel Dis. 2012;18:2004\u201310.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"516_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749\u201353.","journal-title":"Gut"},{"issue":"1","key":"516_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-2893.2008.01037.x","volume":"16","author":"HL Chan","year":"2009","unstructured":"Chan HL, Wong GL, Choi PC, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat. 2009;16(1):36\u201344.","journal-title":"J Viral Hepat"},{"key":"516_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/gut.2008.157735","volume":"58","author":"GL Wong","year":"2009","unstructured":"Wong GL, Wong VW, Choi PC, et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut. 2009;58:111\u20137.","journal-title":"Gut"},{"issue":"4","key":"516_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.crohns.2013.08.017","volume":"8","author":"ML Huang","year":"2014","unstructured":"Huang ML, et al. Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: A retrospective study. J Crohn\u2019s Colitis. 2014;8(4):282\u20137.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"5","key":"516_CR22","first-page":"8078","volume":"8","author":"Y He","year":"2015","unstructured":"He Y, et al. Prevalence and influences of hepatitis B virus infection on inflammatory bowel disease: a retrospective study in southern China. International journal of clinical and experimental medicine. 2015;8(5):8078\u201385.","journal-title":"International journal of clinical and experimental medicine"},{"key":"516_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","volume":"27","author":"W Yeo","year":"2009","unstructured":"Yeo W, Chan TC, Leung NW, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol. 2009;27:605\u201311.","journal-title":"J Clin Oncol"},{"issue":"11","key":"516_CR24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/1751-2980.12089","volume":"14","author":"WK Leung","year":"2013","unstructured":"Leung WK, Liu KSH, Seto WKW, et al. Factors for Hepatitis B vaccination and Abnormal Liver Function in Chinese Patients with Inflammatory Bowel Disease: A Single Center Experience. J Dig Dis. 2013;14(11):596\u2013603.","journal-title":"J Dig Dis"},{"issue":"10","key":"516_CR25","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/j.1365-2036.2007.03506.x","volume":"26","author":"SG Lim","year":"2007","unstructured":"Lim SG, Marcellin P, Tassopoulos N, et al. Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B. Aliment Pharmacol Ther. 2007;26(10):1419\u201328.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"516_CR26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0016-5085(81)80002-9","volume":"81","author":"GH Scullard","year":"1981","unstructured":"Scullard GH, Smith C, Merigan TC, et al. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology. 1981;81(6):987\u201391.","journal-title":"Gastroenterology"},{"key":"516_CR27","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/hep.1840120505","volume":"12","author":"IR Wanless","year":"1990","unstructured":"Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology. 1990;12:1106\u201310.","journal-title":"Hepatology"},{"issue":"6","key":"516_CR28","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/ajg.2009.733","volume":"105","author":"SK Wasan","year":"2010","unstructured":"Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010;105(6):1231\u20138.","journal-title":"Am J Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-016-0516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-016-0516-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-016-0516-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-016-0516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:27:25Z","timestamp":1718756845000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-016-0516-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["516"],"URL":"https:\/\/doi.org\/10.1186\/s12876-016-0516-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]},"article-number":"100"}}